.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

PROPECIA Drug Profile

« Back to Dashboard
Propecia is a drug marketed by Merck and is included in one NDA. It is available from three suppliers.

The generic ingredient in PROPECIA is finasteride. There are fourteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the finasteride profile page.

Summary for Tradename: PROPECIA

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list3

Pharmacology for Tradename: PROPECIA

Clinical Trials for: PROPECIA

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck
PROPECIA
finasteride
TABLET;ORAL020788-001Dec 19, 1997RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PROPECIA

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck
PROPECIA
finasteride
TABLET;ORAL020788-001Dec 19, 19974,377,584<disabled>
Merck
PROPECIA
finasteride
TABLET;ORAL020788-001Dec 19, 19975,886,184<disabled>
Merck
PROPECIA
finasteride
TABLET;ORAL020788-001Dec 19, 19975,547,957<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc